Delivery Order SPE2DB20D3103-SPE2DB25FN5E8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ezetimibe 10 mg tablets in quantities of 500 units. This contract, valued at $3,910.92, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is to be completed by September 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ezetimibe-Simvastatin 10-40 mg tablets in a quantity of 1,000 units. Valued at $1,091.55 with a firm fixed price structure, this non-set-aside contract is scheduled for completion by September 2, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,033.38 to Amerisourcebergen Drug Corporation for 500 tablets of Ezetimibe 10 mg. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 23 to August 24, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor to supply the generic cholesterol medication to the Defense Logistics...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ezetimibe 10 mg tablets. The $8,313.85 firm fixed-price contract has a performance period through May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $426 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to supply 500 tablets of the pharmaceutical product Ezetimibe 10 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 10-11, 2023. No major subcontractors or set aside designations were indicated. This order is likely placed...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,097.54 firm fixed price delivery order is for the supply of Ezetimibe 10 mg tablets, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp does not hold any set-aside designations for this award. The contract is part of a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $129,000 to Amerisourcebergen Drug Corporation for 500 tablets of the cholesterol-lowering drug ezetimibe. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the one-day period of July 17-18, 2023. The order was placed under an existing DLA contract vehicle to support the Agency's logistics and procurement missions....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,196.15 firm-fixed-price delivery order is for the supply of 4,565,243,581 units of the drug ezetimibe 10 mg tablets. There is no set-aside designation for this contract, which has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $52,420 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 90 count bottles of 10 mg Ezetimibe tablets. To be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the order is for product delivery between September 22 and 25, 2023. As a major supplier of pharmaceuticals to the Department of Defense, AmerisourceBergen will fulfill this requirement for the cholesterol-lowering medication to support...
- The Defense Logistics Agency awarded a delivery order valued at $401.46 to Amerisourcebergen Drug Corporation for the provision of 500 tablets of Ezetimibe 10 mg. The contract has a firm fixed price and requires delivery to a facility in Conshohocken, Pennsylvania between August 16-17, 2023. Amerisourcebergen will supply the pharmaceutical product to the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, in support of its mission to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN5E8Delivery Order
The Defense Logistics Agency awarded a $1,086.00 delivery order to AmerisourceBergen Drug Corp for Ezetimibe 10 mg tablets (20-count unit dose packaging) on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle valued through December 2026 that enables the company to supply comprehensive pharmaceutical and medical commodities globally to support military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with particular focus on military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order represents a small-value transaction characteristic of the company's versatility in fulfilling routine federal medical supply requirements under its existing DLA prime vendor framework, which positions it as a primary source for pharmaceutical support across Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/21/25 |